Westat Supports Largest Nationwide SARS-CoV-2 Seroprevalence Survey

The serosurvey tests individual residual blood donor samples for SARS-CoV-2 antibodies.

For the Centers for Disease Control and Prevention (CDC), Westat, partnering with Vitalant Research Institute, has launched a large nationwide SARS-CoV-2 seroprevalence survey. This high-profile large-scale serosurvey encompassing all 50 states, Puerto Rico, and the District of Columbia is CDC’s first major effort to learn more about the percentage of people in the United States who have been infected with SARS-CoV-2, the virus that causes COVID-19, and to better understand how the virus is spreading through the U.S. population over time. 

The serosurvey is being conducted in 60+ metropolitan areas in the United States and collects and tests 2,000 individual residual blood donor samples monthly from each participating area for 12 months, with a final collection at 18 months.

Using U.S. census data for each metropolitan area, Westat statisticians are making weighting determinations to extrapolate seroprevalence results in blood donor samples to the general population to determine overall seroprevalence for each month in each metropolitan area.

Westat will conduct repeated cycles of data collection, coordination, data management, and analysis throughout the investigation period in order to successfully translate sample-based seroprevalence to the general population. Results will be presented and updated on CDC’s COVID dashboard and made available to the general public.

Sunitha Mathew is leading this effort as the project director along with a team that includes Jean Opsomer, Ph.D., as lead statistician, Rebecca Fink as project manager, Matthew Levy and Carly Hallowell of Westat’s Public Health and Epidemiology Practice Area, and a large team of systems and statistical staff.

See CDC’s website for details: Multistate Assessment of SARS-CoV-2 Seroprevalence in Blood Donors

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Substance Abuse and Mental Health Services Administration
The National Institutes of Health
AAA Foundation for Traffic Safety
The Johns Hopkins University
University of Maryland Baltimore Campus
University of Denver
U.S. Department of Veterans Affairs
U.S. Department of Transportation
U.S. Department of Justice
U.S. Department of Health and Human Services
U.S. Department of Education
U.S. Department of Agriculture
The Verizon Foundation
Texas Education Agency
Baltimore Metropolitan Council
Teach for America
Social Security Administration
Robert Wood Johnson Foundation
Organization for Economic Cooperation and Development
NYC Mayor’s Office for Economic Opportunity
National Science Foundation
Michigan Department of Health and Human Services
Maryland Cancer Registry
Internal Revenue Service
Georgia Department of Transportation
DC Public Schools
ClearWay Minnesota
Chicago Metropolitan Agency for Planning
University of Michigan
Explore Our Clients

Please wait...

Forbes 2020 The Best Employers for Diversity Powered by Statista Copyright 2019 Forbes Media LLC. Used with permissionForbes 2019: The Best Employers for Women Powered by Statista Copyright 2019 Forbes Media LLC. Used with permission

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.